← Insider buys
AKRO

Akero Therapeutics, Inc. · HEALTHCARE

Versant Venture Capital Vi, L.P. sold $9.4M of Akero Therapeutics, Inc.

10% owner

Sold$9,421,175
$24.20Price
389,382Shares
−10%Stake

What AKRO did after the filing

Prices for AKRO after this filing aren't in yet.

Traded Fri, Dec 27. Filed Tue, Dec 31. Not investment advice.